Delivery Order SPE2DB22D2218-SPE2DB25FR2ML
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,495.84 to AmerisourceBergen Drug Corp for the supply of Gentamicin 800 mg/20 mL vials. This competitively awarded, firm fixed-price contract represents a single delivery order with an ultimate completion date of September 29, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competed openly...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gentamicin 800 mg/20 mL vials totaling $1,791.07. This is a firm fixed-price delivery order under a non-competitive award with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued as a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on June 26, 2025, for the supply of Gentamicin 800 mg/20 mL vials with a contract value of $1,987.23 and an ultimate completion date of June 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery supporting federal...
- The Defense Logistics Agency awarded a $10,558.45 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gentamicin pediatric 20 mg/2 mL vials. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a competitively awarded (non-set-aside) procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, valued at $2,292.52, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gentamicin is a critical antibiotic used in military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,286.51, is for the delivery of 4,568,577,972 vials of 800 mg/20 mL Gentamicin, a pharmaceutical product used for treating various bacterial infections. The contract has an ultimate completion date of June 18, 2025 and is not set aside for any specific business type....
- This is a firm fixed price delivery order worth $2,234.97, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,988,152 units of the pharmaceutical product Gentamicin 800 mg/20 ml vial. The order has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $147 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg/2 ml vials of the antibiotic gentamicin. As the prime contractor, Amerisourcebergen will deliver the gentamicin pediatric medication to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania by September 28, 2023 under the terms of the order. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,460 to Amerisourcebergen Drug Corporation for gentamicin 0.3% eye drops. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements by August 31, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $7,680 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561811613 Gentamicin 0.3% eye drops in 5mL bottles. Performance will take place in Conshohocken, Pennsylvania over one day in mid-August 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense's procurement and distribution of pharmaceuticals and other...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR2MLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gentamicin 800 mg/20 mL vials with a ceiling value of $1,120.31 under a firm fixed price contract. The award was made on May 8, 2025, with an ultimate completion date of May 9, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The gentamicin delivery supports the Defense Health Agency and other federal healthcare systems' antimicrobial treatment requirements across military and veteran care networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/8/25 |